[Metabolic syndrome in dialyzed patients. Advanced glycation end-products, adipocytokines, and principles of treatment].
Metabolic syndrome (MeS) in dialyzed patients, especially in peritoneal dialysis, runs with increased serum concentration of adipocytokines and intensified the process of advanced glycation end-product formation and its consequences. Treatment of MeS in dialyzed patients is as difficult as in general population. Attention was paid for therapeutic aspects, associated with treatment of end-stage renal disease and with dialysis procedure, which may influence the course of MeS.
Grzegorzewska
Alicja E
AE
Uniwersytet Medyczny w Poznaniu, Katedra i Klinika Nefrologii, Transplantologii i Chorób Wewnetrznych. alicja_grzegorzewska@yahoo.com
D054392:Adipokines / Q000097:blood*; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D024821:Metabolic Syndrome / Q000209:etiology* / Q000378:metabolism* / Q000517:prevention & control / Q000628:therapy; D006435:Renal Dialysis / Q000009:adverse effects* / Q000379:methods
D054392:Adipokines; D017127:Glycation End Products, Advanced